Endometrial effects of a single early luteal dose of the selective progesterone receptor modulator CDB-2914 - Wikidata - wikimedia - TriplyDB

Endometrial effects of a single early luteal dose of the selective progesterone receptor modulator CDB-2914

Endometrial effects of a single early luteal dose of the selective progesterone receptor modulator CDB-2914

http://www.wikidata.org/entity/Q24601691

about

Mechanism of Action of Ulipristal Acetate for Emergency Contraception: A Systematic Review Selective progesterone receptor modulators: an update Ulipristal acetate: contraceptive or contragestive?Emergency contraception: potential role of ulipristal acetate Update on emergency contraception.A randomized study on pharmacodynamic effects of vaginal rings delivering the progesterone receptor modulator ulipristal acetate: research for a novel estrogen-free, method of contraception.Results from pooled Phase III studies of ulipristal acetate for emergency contraception Emergency contraception: an updated review.Emerging options for emergency contraception.Mechanisms of action of oral emergency contraception.Effects of ulipristal acetate on human embryo attachment and endometrial cell gene expression in an in vitro co-culture system.Efficacy of ulipristal acetate for emergency contraception and its effect on the subsequent bleeding pattern when administered before or after ovulation.The role of progesterone signaling in the pathogenesis of uterine leiomyoma Immunopharmacology of ulipristal as an emergency contraceptive.Emergency contraception. Widely available and effective but disappointing as a public health intervention: a review Ulipristal acetate, a progesterone receptor modulator for emergency contraception.Emerging female contraceptives.Ulipristal acetate: a review of its use in emergency contraception.Ulipristal acetate: a new emergency contraceptive.Contraceptives with novel benefits.Ulipristal acetate as an emergency contraceptive agent.Ulipristal acetate: critical review about endometrial and ovulatory effects in emergency contraception.Consequences of emergency contraceptives: the adverse effects.Pharmacokinetic and pharmacodynamic drug interactions between antiretrovirals and oral contraceptives.Ovarian and oocyte targets for development of female contraceptives.The use of selective progestin receptor modulators (SPRMs) and more specifically ulipristal acetate in the practice of gynaecology.Current controversies with oral emergency contraception.Ulipristal acetate - safety and pharmacokinetics following multiple doses of 10-50 mg per day.Effect of ulipristal acetate and mifepristone at emergency contraception dose on the embryo-endometrial attachment using an in vitro human trophoblastic spheroid and endometrial cell co-culture model.An emergency contraception algorithm based on risk assessment: changes in clinicians' practice and patients' choices.Effect of exposure to ulipristal acetate on sperm function.A Comprehensive Review of the Pharmacologic Management of Uterine Leiomyoma.Emergency Contraception Clinical Pharmacology of Hormonal Emergency Contraceptive Pills

P2860

Q26770436-6F6D5542-59F2-44BC-9A81-686346989C69 Q28239255-055D423E-DBA5-4056-9478-D0BA1F62FCB1 Q34191909-6585D039-8B24-43D6-A8F4-81FE3A93559F Q34272222-5A9C5914-24CC-42B7-81B3-427334DDB15A Q34305013-3638FA5E-B109-45AF-B2D0-BA49F1D112F9 Q34620635-199D4D0D-45B6-45C1-9D5B-E41682D51C2E Q34640054-F9499174-E924-4C21-9ED3-94573074D3D2 Q34654865-1531E214-1B5C-4AF4-8E3F-AFB3BD9D08BB Q34659150-10699BE2-A759-4861-BEB9-17188560BB2B Q34663916-2677DC1C-DB93-48AA-9A3E-0C67F052B293 Q34668355-7E715516-6D6D-4DB3-B70A-2A444BDEB8E0 Q34676784-FC2A28FA-51EC-441A-9F2E-D99F75E08C4E Q35249360-CE009BCD-29CB-482D-92C6-BD3F9701BB4B Q35577049-2E82A76F-FAFB-4367-80D1-1AD5EAD708CC Q35661760-F261C235-F161-44B3-AAF9-86AE00D1E967 Q35975207-509E5F12-3A47-4F0D-95B7-96D363214CFC Q37828533-64B49F97-0017-4C2C-AC8A-773DD92DC571 Q37875065-DF216CCB-CD27-43C2-B9B6-3D6ADB0D0EF2 Q37960522-2596DF38-23E8-4313-8047-EEAC3DD6B208 Q37965736-80F2DC79-B849-4EBB-9D76-12876758004B Q38024429-268EB01D-3D90-4809-AA02-DB3979CB466A Q38179825-8221AEAE-DFC1-41C9-9D53-E5459E06C661 Q38219426-BBA4CE2D-51BA-4148-B3AD-FDB179BCB871 Q38261574-725AFFE8-1C8F-46F1-838F-056FC499C145 Q38509792-0E54F485-A45E-41E7-BA96-B6B8D83BC1BC Q38676367-A67A2034-3DCA-4562-9C0B-0F62B1526B52 Q39402949-DDEE401D-8CD8-457C-9138-71D3A227BB0D Q42712110-9EBFF011-DB9F-412D-BBED-1F8AFE2A84F7 Q47221830-63DAE5CC-5689-4926-9272-3F9CF7F9C0B9 Q51253207-4596CB8F-9B56-4885-BC10-AFAE97F12915 Q51296023-064D65B0-DD88-48EF-AD6F-4AC836D89ABB Q55399257-491164BA-6CF3-4D38-951C-4BD03B4B7BC4 Q56051166-606B5F97-FE9B-4B36-ADEB-3F227C9DC426 Q58584448-E53E1760-643C-42FB-86C5-912E2DD52CD6

P2860

Endometrial effects of a single early luteal dose of the selective progesterone receptor modulator CDB-2914

http://www.wikidata.org/entity/Q24601691

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Endometrial effects of a singl ...... ne receptor modulator CDB-2914

@ast

Endometrial effects of a singl ...... ne receptor modulator CDB-2914

@en

Endometrial effects of a singl ...... ne receptor modulator CDB-2914

@nl

type

label

Endometrial effects of a singl ...... ne receptor modulator CDB-2914

@ast

Endometrial effects of a singl ...... ne receptor modulator CDB-2914

@en

Endometrial effects of a singl ...... ne receptor modulator CDB-2914

@nl

prefLabel

Endometrial effects of a singl ...... ne receptor modulator CDB-2914

@ast

Endometrial effects of a singl ...... ne receptor modulator CDB-2914

@en

Endometrial effects of a singl ...... ne receptor modulator CDB-2914

@nl

P1433

Q24601691-C41DEADA-EFDB-44FA-B914-97B198C7916A

P1476

Q24601691-4946A2B0-5342-4230-9A30-B9245342A0E9

P2093

Q24601691-44C7F663-C08F-4D51-9945-BBACFF5E50B1

Q24601691-7FB8746E-995A-4F97-A7F9-D979A262ED67

Q24601691-896BB7D0-75B9-4727-A9EF-B66AE860CF5E

Q24601691-8B138B02-90FA-43AD-A57B-EEC2CC6F83BC

Q24601691-BA0C516E-06FC-488D-B207-D89D1766A942

Q24601691-D860BA55-D073-4951-8A11-3A4BDFC42572

Q24601691-F426FDE5-8F8F-460B-B3DA-F995991E109F

P2860

Q24601691-029EAE83-7F08-447B-8CAC-7D4F0F775A32

Q24601691-2181BE77-2E26-43AE-A72F-6267FFAEEE44

Q24601691-296AB43E-1F3A-4141-BFE4-23CC32E47205

Q24601691-2B29BA5B-B407-447C-AEE8-015DAAB0E943

Q24601691-2F5F8AE1-C23C-49B0-87B3-CB91268BACD6

Q24601691-36A6D5D0-39C6-4868-8367-69221388D589

Q24601691-508B52AE-0258-4998-BC4F-DAB241CA9186

Q24601691-5B49095B-36B3-49E5-9D6C-6A93CABC5AC1

Q24601691-5D942228-06ED-45B8-8680-A5953FC50F33

Q24601691-876F2B7D-754F-4450-9D6C-41EFA01D3AA5

P304

Q24601691-842C18B3-230D-40D1-B7F5-DB159BD350EC

P31

Q24601691-046135E6-C04B-47AF-B0A6-A683E31FAB8B

P356

Q24601691-D8342BD6-5856-41A8-B623-1CA54BD15555

P407

Q24601691-4432668B-804C-44BD-BAAE-45A28519AC65

P433

Q24601691-FF75EC07-E8E7-4F79-A1C8-9FA3F0340A1E

P478

Q24601691-BC4459BA-5733-4B50-BAC2-419E848256E5

P577

Q24601691-23826DAA-0B8D-4D70-852F-A56F1B980781

P5875

Q24601691-5B536ADE-BCA1-4A66-BD6B-DD4140E68617

P698

Q24601691-F18B2B51-3265-4622-A646-1688C6B7F80B

P921

Q24601691-4E08A377-77D8-4210-947C-F96EFBBA1B2C

Q24601691-9CF8BDA1-E04F-4072-9D01-B3391D10A5B2

P932

Q24601691-D8F6F101-00B7-471A-89F3-A04A8F3A00D0

P356

J.FERTNSTERT.2008.12.057

P1433

Fertility and Sterility

P1476

Endometrial effects of a singl ...... ne receptor modulator CDB-2914

@en

P2093

Beth Hartog

http://www.w3.org/2001/XMLSchema#string

Eric D Levens

http://www.w3.org/2001/XMLSchema#string

Johann Piquion

http://www.w3.org/2001/XMLSchema#string

Lynnette K Nieman

http://www.w3.org/2001/XMLSchema#string

Maria Merino

http://www.w3.org/2001/XMLSchema#string

Pamela Stratton

http://www.w3.org/2001/XMLSchema#string

Qingxiang Wei

http://www.w3.org/2001/XMLSchema#string

P2860

Progesterone receptor modulator for emergency contraception: a randomized controlled trial

The antagonists RU486 and ZK98299 stimulate progesterone receptor binding to deoxyribonucleic acid in vitro and in vivo, but have distinct effects on receptor conformation

Trophoblast L-selectin-mediated adhesion at the maternal-fetal interface.

Mechanisms of action of mifepristone and levonorgestrel when used for emergency contraception.

Expression of L-selectin ligand MECA-79 as a predictive marker of human uterine receptivity.

Mifepristone (RU 486) compared with high-dose estrogen and progestogen for emergency postcoital contraception.

The effects of an antiprogestin, mifepristone, and an antiestrogen, tamoxifen, on endometrial 17 beta-hydroxysteroid dehydrogenase and progestin and estrogen receptors during the luteal phase of the menstrual cycle: an immunohistochemical study.

Correlation of endometrial maturation with four methods of estimating day of ovulation.

Interruption of endometrial maturation without hormonal changes by an antiprogesterone during the first half of luteal phase of the menstrual cycle: a contraceptive potential.

Luteal phase dose-response relationships of the antiprogestin CDB-2914 in normally cycling women.

P304

2035-41

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.FERTNSTERT.2008.12.057

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

93

http://www.w3.org/2001/XMLSchema#string

P577

2010-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23988438

http://www.w3.org/2001/XMLSchema#string

P698

19200989

http://www.w3.org/2001/XMLSchema#string

P921

reproductive medicine

obstetrics and gynaecology

P932

2911236

http://www.w3.org/2001/XMLSchema#string